September 01, 2021

Looking Ahead to Factors Shaping Market Activity

A bylined article exploring the factors shaping M&A activity in the life sciences sector by EMEA CRO Merlin Piscitelli was published in the September issue of Pharmaceutical Technology Europe. The article highlights how the sector continues to attract investor interest despite unprecedented disruption caused by the pandemic. 

Contacts

Media Relations
Marta Carraro

Vice President, Communications

212.367.6162

[email protected]

Investor Relations
Jennifer Percy

Senior Vice President, Finance & Treasury

651.632.4009

[email protected]

You may also like:

Soft Skills Still Required – but Technology is Improving M&A Processes & Valuations

Chief Product & Strategy Officer Doug Cullen writes about how technology is improving M&A processes and valuations.

Global Banking & Finance Review
Fintech M&A Deal Tracker: Banks Regain Appetite for Buying Fintechs

EMEA CRO Merlin Piscitelli discusses the outlook for fintech M&A amidst a tighter funding environment.

S & P Global
The Optimistic Outlook for Healthcare M&A

Americas CRO Mark Williams writes that as healthcare providers continue to look for ways to reflect a world more focused on digital care and the consumer experience, M&A could rise over the next year.